Injection site reaction assessment. 7. Whole blood and serum for immunologic assays. 37 Date: 8 April 2016 v 2.1 INO-3112 UPCC # 39313 / Inovio HPV -005 Inovio Pharmaceuticals, Inc Clinical Protocol 6.1.7 Long term follow up (every 3 months ±7 days for 6 months )/End of study visit Long term follow up for 6 months from the last dose of immunotherapy. End of study visit will be the last long term follow up visit .